SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases.

MLA

Di Costanzo, Assunta, et al. “SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases.” International Journal of Molecular Sciences, vol. 24, no. 10, May 2023, p. 8732. EBSCOhost, https://doi.org/10.3390/ijms24108732.

APA

Di Costanzo, A., Esposito, G., Indolfi, C., & Spaccarotella, C. A. M. (2023). SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases. International Journal of Molecular Sciences, 24(10), 8732. https://doi.org/10.3390/ijms24108732

Chicago

Di Costanzo, Assunta, Giovanni Esposito, Ciro Indolfi, and Carmen Anna Maria Spaccarotella. 2023. “SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases.” International Journal of Molecular Sciences 24 (10): 8732. doi:10.3390/ijms24108732.